相关实验视频
Updated: Jul 13, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
概括
索托拉西布是一种KRASG12C抑制剂,由于试验设计问题和无进展生存结果,它面临着对非小细胞肺癌的全面批准的潜在延迟. 需要进一步的研究来证实它的有效性.
科学领域:
- 在瘤学瘤学.
- 医学瘤学 医学瘤学
- 胸部癌症 胸部癌症 癌症
背景情况:
- 索托拉西布是一种针对KRASG12C突变非小细胞肺癌 (NSCLC) 的向疗法.
- CodeBreaK 200试验是一项确认性III期研究,评估了二线设置中的索托拉西布.
- 之前的研究表明了潜在的益处,但确认数据对于完全批准至关重要.
研究的目的:
- 为了评估与标准化疗相比,索托拉西布的疗效和安全性,先前治疗过转移性KRASG12C突变NSCLC的患者.
- 为索托拉西布 (Sotorasib) 获得全面监管批准提供确认数据.
主要方法:
- CodeBreaK 200 是一个随机的,开放的,III期试验.
- 患者接受了索托拉西布或多塞塔克塞尔.
- 无进展生存 (PFS) 是主要终点.
主要成果:
- 试验遇到了一些设计挑战.
- 没有进展的生存数据不符合对优势的预期.
- 这些令人失望的结果可能会影响该药物的全面批准.
结论:
- 在CodeBreaK 200中的设计缺陷和低于最佳的PFS数据引起了人们对索托拉西布作为KRASG12CNSC的二线治疗疗法的有效性的担忧.
- 索托拉西布的全面批准可能取决于额外的临床研究.
- 需要进一步的研究来澄清索托拉西布在这种患者群体中的作用.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Structure-Activity Relationships and Drug Design
737
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
737
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K